The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Streptokinase-Global Market Insights and Sales Trends 2025
Synopsis
Streptokinase is indicated for the treatment of AMI, acute massive pulmonary embolism (PE), deep vein thrombosis (DVT), arterial thrombosis, and occluded arteriovenous cannulae.
The global Streptokinase market size is expected to reach US$ 526.1 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Streptokinase in various end use industries. The expanding demands from the Myocardial Infarction (MI), Deep Vein Thrombosis, Pulmonary Embolism and Others, are propelling Streptokinase market. High IU, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low IU segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Streptokinase market, driven by demand from China, the second largest economy with some signs of stabilising, the Streptokinase market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Streptokinase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Streptokinase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Streptokinase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Streptokinase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Streptokinase covered in this report include SAMARTH PHARMA, Biocon, Kee Pharma, Dabur, Biosena, Wanbang Biopharma, Qingdao GD Biotechnology Pharmaceutical, Aristo Pharmaceuticals and Neiss Labs, etc.
The global Streptokinase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SAMARTH PHARMA
Biocon
Kee Pharma
Dabur
Biosena
Wanbang Biopharma
Qingdao GD Biotechnology Pharmaceutical
Aristo Pharmaceuticals
Neiss Labs
Ahaan Healthcare Pvt Ltd. (AHPL)
Biofactor
TTK HealthCare
Incepta Pharmaceuticals Limited
Cadila
Global Streptokinase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Streptokinase market, Segment by Type:
High IU
Low IU
Global Streptokinase market, by Application
Myocardial Infarction (MI)
Deep Vein Thrombosis
Pulmonary Embolism
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Streptokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Streptokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Streptokinase is indicated for the treatment of AMI, acute massive pulmonary embolism (PE), deep vein thrombosis (DVT), arterial thrombosis, and occluded arteriovenous cannulae.
The global Streptokinase market size is expected to reach US$ 526.1 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029. The market is mainly driven by the significant applications of Streptokinase in various end use industries. The expanding demands from the Myocardial Infarction (MI), Deep Vein Thrombosis, Pulmonary Embolism and Others, are propelling Streptokinase market. High IU, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low IU segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Streptokinase market, driven by demand from China, the second largest economy with some signs of stabilising, the Streptokinase market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Streptokinase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Streptokinase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Streptokinase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Streptokinase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Streptokinase covered in this report include SAMARTH PHARMA, Biocon, Kee Pharma, Dabur, Biosena, Wanbang Biopharma, Qingdao GD Biotechnology Pharmaceutical, Aristo Pharmaceuticals and Neiss Labs, etc.
The global Streptokinase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SAMARTH PHARMA
Biocon
Kee Pharma
Dabur
Biosena
Wanbang Biopharma
Qingdao GD Biotechnology Pharmaceutical
Aristo Pharmaceuticals
Neiss Labs
Ahaan Healthcare Pvt Ltd. (AHPL)
Biofactor
TTK HealthCare
Incepta Pharmaceuticals Limited
Cadila
Global Streptokinase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Streptokinase market, Segment by Type:
High IU
Low IU
Global Streptokinase market, by Application
Myocardial Infarction (MI)
Deep Vein Thrombosis
Pulmonary Embolism
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Streptokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Streptokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Streptokinase Market Overview
1.1 Streptokinase Product Overview
1.2 Streptokinase Market Segment by Type
1.2.1 High IU
1.2.2 Low IU
1.3 Global Streptokinase Market Size by Type
1.3.1 Global Streptokinase Market Size Overview by Type (2018-2029)
1.3.2 Global Streptokinase Historic Market Size Review by Type (2018-2023)
1.3.3 Global Streptokinase Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Streptokinase Sales Breakdown by Type (2018-2023)
1.4.2 Europe Streptokinase Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Streptokinase Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Streptokinase Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Streptokinase Sales Breakdown by Type (2018-2023)
2 Global Streptokinase Market Competition by Company
2.1 Global Top Players by Streptokinase Sales (2018-2023)
2.2 Global Top Players by Streptokinase Revenue (2018-2023)
2.3 Global Top Players by Streptokinase Price (2018-2023)
2.4 Global Top Manufacturers Streptokinase Manufacturing Base Distribution, Sales Area, Product Type
2.5 Streptokinase Market Competitive Situation and Trends
2.5.1 Streptokinase Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Streptokinase Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Streptokinase as of 2022)
2.7 Date of Key Manufacturers Enter into Streptokinase Market
2.8 Key Manufacturers Streptokinase Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Streptokinase Status and Outlook by Region
3.1 Global Streptokinase Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Streptokinase Historic Market Size by Region
3.2.1 Global Streptokinase Sales in Volume by Region (2018-2023)
3.2.2 Global Streptokinase Sales in Value by Region (2018-2023)
3.2.3 Global Streptokinase Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Streptokinase Forecasted Market Size by Region
3.3.1 Global Streptokinase Sales in Volume by Region (2024-2029)
3.3.2 Global Streptokinase Sales in Value by Region (2024-2029)
3.3.3 Global Streptokinase Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Streptokinase by Application
4.1 Streptokinase Market Segment by Application
4.1.1 Myocardial Infarction (MI)
4.1.2 Deep Vein Thrombosis
4.1.3 Pulmonary Embolism
4.1.4 Others
4.2 Global Streptokinase Market Size by Application
4.2.1 Global Streptokinase Market Size Overview by Application (2018-2029)
4.2.2 Global Streptokinase Historic Market Size Review by Application (2018-2023)
4.2.3 Global Streptokinase Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Streptokinase Sales Breakdown by Application (2018-2023)
4.3.2 Europe Streptokinase Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Streptokinase Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Streptokinase Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Streptokinase Sales Breakdown by Application (2018-2023)
5 North America Streptokinase by Country
5.1 North America Streptokinase Historic Market Size by Country
5.1.1 North America Streptokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Streptokinase Sales in Volume by Country (2018-2023)
5.1.3 North America Streptokinase Sales in Value by Country (2018-2023)
5.2 North America Streptokinase Forecasted Market Size by Country
5.2.1 North America Streptokinase Sales in Volume by Country (2024-2029)
5.2.2 North America Streptokinase Sales in Value by Country (2024-2029)
6 Europe Streptokinase by Country
6.1 Europe Streptokinase Historic Market Size by Country
6.1.1 Europe Streptokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Streptokinase Sales in Volume by Country (2018-2023)
6.1.3 Europe Streptokinase Sales in Value by Country (2018-2023)
6.2 Europe Streptokinase Forecasted Market Size by Country
6.2.1 Europe Streptokinase Sales in Volume by Country (2024-2029)
6.2.2 Europe Streptokinase Sales in Value by Country (2024-2029)
7 Asia-Pacific Streptokinase by Region
7.1 Asia-Pacific Streptokinase Historic Market Size by Region
7.1.1 Asia-Pacific Streptokinase Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Streptokinase Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Streptokinase Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Streptokinase Forecasted Market Size by Region
7.2.1 Asia-Pacific Streptokinase Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Streptokinase Sales in Value by Region (2024-2029)
8 Latin America Streptokinase by Country
8.1 Latin America Streptokinase Historic Market Size by Country
8.1.1 Latin America Streptokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Streptokinase Sales in Volume by Country (2018-2023)
8.1.3 Latin America Streptokinase Sales in Value by Country (2018-2023)
8.2 Latin America Streptokinase Forecasted Market Size by Country
8.2.1 Latin America Streptokinase Sales in Volume by Country (2024-2029)
8.2.2 Latin America Streptokinase Sales in Value by Country (2024-2029)
9 Middle East and Africa Streptokinase by Country
9.1 Middle East and Africa Streptokinase Historic Market Size by Country
9.1.1 Middle East and Africa Streptokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Streptokinase Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Streptokinase Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Streptokinase Forecasted Market Size by Country
9.2.1 Middle East and Africa Streptokinase Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Streptokinase Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SAMARTH PHARMA
10.1.1 SAMARTH PHARMA Company Information
10.1.2 SAMARTH PHARMA Introduction and Business Overview
10.1.3 SAMARTH PHARMA Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.1.4 SAMARTH PHARMA Streptokinase Products Offered
10.1.5 SAMARTH PHARMA Recent Development
10.2 Biocon
10.2.1 Biocon Company Information
10.2.2 Biocon Introduction and Business Overview
10.2.3 Biocon Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Biocon Streptokinase Products Offered
10.2.5 Biocon Recent Development
10.3 Kee Pharma
10.3.1 Kee Pharma Company Information
10.3.2 Kee Pharma Introduction and Business Overview
10.3.3 Kee Pharma Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Kee Pharma Streptokinase Products Offered
10.3.5 Kee Pharma Recent Development
10.4 Dabur
10.4.1 Dabur Company Information
10.4.2 Dabur Introduction and Business Overview
10.4.3 Dabur Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Dabur Streptokinase Products Offered
10.4.5 Dabur Recent Development
10.5 Biosena
10.5.1 Biosena Company Information
10.5.2 Biosena Introduction and Business Overview
10.5.3 Biosena Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biosena Streptokinase Products Offered
10.5.5 Biosena Recent Development
10.6 Wanbang Biopharma
10.6.1 Wanbang Biopharma Company Information
10.6.2 Wanbang Biopharma Introduction and Business Overview
10.6.3 Wanbang Biopharma Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Wanbang Biopharma Streptokinase Products Offered
10.6.5 Wanbang Biopharma Recent Development
10.7 Qingdao GD Biotechnology Pharmaceutical
10.7.1 Qingdao GD Biotechnology Pharmaceutical Company Information
10.7.2 Qingdao GD Biotechnology Pharmaceutical Introduction and Business Overview
10.7.3 Qingdao GD Biotechnology Pharmaceutical Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Qingdao GD Biotechnology Pharmaceutical Streptokinase Products Offered
10.7.5 Qingdao GD Biotechnology Pharmaceutical Recent Development
10.8 Aristo Pharmaceuticals
10.8.1 Aristo Pharmaceuticals Company Information
10.8.2 Aristo Pharmaceuticals Introduction and Business Overview
10.8.3 Aristo Pharmaceuticals Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aristo Pharmaceuticals Streptokinase Products Offered
10.8.5 Aristo Pharmaceuticals Recent Development
10.9 Neiss Labs
10.9.1 Neiss Labs Company Information
10.9.2 Neiss Labs Introduction and Business Overview
10.9.3 Neiss Labs Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Neiss Labs Streptokinase Products Offered
10.9.5 Neiss Labs Recent Development
10.10 Ahaan Healthcare Pvt Ltd. (AHPL)
10.10.1 Ahaan Healthcare Pvt Ltd. (AHPL) Company Information
10.10.2 Ahaan Healthcare Pvt Ltd. (AHPL) Introduction and Business Overview
10.10.3 Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ahaan Healthcare Pvt Ltd. (AHPL) Streptokinase Products Offered
10.10.5 Ahaan Healthcare Pvt Ltd. (AHPL) Recent Development
10.11 Biofactor
10.11.1 Biofactor Company Information
10.11.2 Biofactor Introduction and Business Overview
10.11.3 Biofactor Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Biofactor Streptokinase Products Offered
10.11.5 Biofactor Recent Development
10.12 TTK HealthCare
10.12.1 TTK HealthCare Company Information
10.12.2 TTK HealthCare Introduction and Business Overview
10.12.3 TTK HealthCare Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.12.4 TTK HealthCare Streptokinase Products Offered
10.12.5 TTK HealthCare Recent Development
10.13 Incepta Pharmaceuticals Limited
10.13.1 Incepta Pharmaceuticals Limited Company Information
10.13.2 Incepta Pharmaceuticals Limited Introduction and Business Overview
10.13.3 Incepta Pharmaceuticals Limited Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Incepta Pharmaceuticals Limited Streptokinase Products Offered
10.13.5 Incepta Pharmaceuticals Limited Recent Development
10.14 Cadila
10.14.1 Cadila Company Information
10.14.2 Cadila Introduction and Business Overview
10.14.3 Cadila Streptokinase Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Cadila Streptokinase Products Offered
10.14.5 Cadila Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Streptokinase Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Streptokinase Industrial Chain Analysis
11.4 Streptokinase Market Dynamics
11.4.1 Streptokinase Industry Trends
11.4.2 Streptokinase Market Drivers
11.4.3 Streptokinase Market Challenges
11.4.4 Streptokinase Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Streptokinase Distributors
12.3 Streptokinase Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
